Advertisement
  • In It for the Long Haul

    Doctors and researchers met online to discuss how the coronavirus pandemic changed cancer care in its early months, as well as how they can improve care and advocate for patients going forward.

    by Kate Yandell

  • The Return to Work

    What happens if your workplace reopens before you’re ready to return or you’re an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

    by Jen Tota McGivney

  • From the Editor-In-Chief

    Measuring a Cancer Drug’s Effectiveness

    Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

    by William G. Nelson, MD, PhD

  • Forward Look

    Here Come the Biosimilars

    As patents expire on biologic drugs, cancer patients get new options.

    by Stephen Ornes

  • Policy Matters

    Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

    The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

    by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

  • Q&A

    Taking the Long View

    In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy.

    by Marci A. Landsmann

  • Parking Costs Take a Hidden Toll on Cancer Patients

    People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.

    by Marcus A. Banks

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • Robotic Surgery and Cancer

    Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

    by Sue Rochman

  • A Modern Family

    My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.

    by Allison Rosen

Advertisement

From the AACR

Advertisement

Video

Handle With Care

Advertisement

social media

donate to the AACR